[The cutting-edge of medicine; novel therapeutic agents for the treatment of diabetes sodium-glucose co-transporter (SGLT) 2 inhibitors].
Department of Internal Medicine, Shiga University of Medical Science, Japan.
Toshiro
T
Sugimoto
Atsunori
A
Kashiwagi
D003920:Diabetes Mellitus / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism; D005960:Glucosides / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012964:Sodium / Q000378:metabolism; D000077203:Sodium-Glucose Transporter 2 Inhibitors
D005960:Glucosides; D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D012964:Sodium; D005947:Glucose